The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients (NCT05838937) | Clinical Trial Compass
UnknownNot Applicable
The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients
Hungary100 participantsStarted 2024-06-01
Plain-language summary
Investigation of the potential prognostic role of non-invasive myocardial work in patients receiving veno-arterial extracorporeal membrane oxygenation therapy.
Who can participate
Age range18 Years – 99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years or older age
* Severe cardiogenic shock requiring the initiation of VA-ECMO therapy
* Stabile hemodynamic state and oxigenation with VA-ECMO and vasoactive support
* Informed written consent (due to the nature of the study, from a legally eligible relative of the patient)
Exclusion Criteria:
* Younger than 18 years of age
* Unstable hemodynamic state or suboptimal oxigenation despite established VA-ECMO and vasoactive support
* Severe neurological damage or confirmed brain death at the time of enrollment which squarely indicates therapy limitation and poor short-term outcome
* Transesophageal echocardiography is contraindicated
* Suboptimal echocardiographic window
What they're measuring
1
Cardiovascular mortality, need for long-term mechanical circulatory support or heart transplantation
Timeframe: 30 days
Trial details
NCT IDNCT05838937
SponsorSemmelweis University Heart and Vascular Center